Influence of the Addition of Trace Amounts of Vinylpyrrolidone–Vinyl Acetate Copolymer (PVPVA) on the Crystallization of Celecoxib Glass
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c00934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Xue Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan. Hauptthemen laut MEDLINE: Celecoxib, Glass, Vinyl Compounds, Polymers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although polymers can prevent the crystallization of glassy drugs in amorphous solid dispersions, their stabilization mechanism requires further clarification for an efficient formulation design. This study examined the impact of adding trace amounts (2 or 5 w/w %) of vinylpyrrolidone-vinyl acetate copolymer (PVPVA) on the physical stability of celecoxib (CEL) glass using differential scanning calorimetry and broadband dielectric spectroscopy. Long-term isothermal crystallization studies from 35 to 60 °C revealed that CEL glass was significantly stabilized by the addition of trace amounts of PVPVA. Its stabilization was attributed to the effect of PVPVA on the nucleation process rather than on crystal growth. The addition of PVPVA slowed down the α-relaxation of CEL, whereas it accelerated Johari-Goldstein relaxation. Moreover, the addition of PVPVA effectively slowed down γ- and δ-relaxations. Of these, suppression of γ-relaxation mobility had the most important effect, as it is related to the formation of hydrogen bonding between CEL and PVPVA molecules to inhibit nucleation. Moreover, the change in molecular cooperativity of the CEL glass upon adding PVPVA contributed to the inhibition of nuclei formation due to the decreased nucleation temperature. This study provides detailed insights into the physical stabilization mechanisms of glass using polymeric excipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.
- Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
ORCID-Profile: Kohsaku Kawakami
Zitieren
APA
Han, X., Ohyama, K., & Kawakami, K. (2026). Influence of the Addition of Trace Amounts of Vinylpyrrolidone–Vinyl Acetate Copolymer (PVPVA) on the Crystallization of Celecoxib Glass. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00934
Vancouver
Han X, Ohyama K, Kawakami K. Influence of the Addition of Trace Amounts of Vinylpyrrolidone–Vinyl Acetate Copolymer (PVPVA) on the Crystallization of Celecoxib Glass. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00934
BibTeX
@article{Han2026,
author = {Han, Xue and Ohyama, Kaoru and Kawakami, Kohsaku},
title = {Influence of the Addition of Trace Amounts of Vinylpyrrolidone–Vinyl Acetate Copolymer (PVPVA) on the Crystallization of Celecoxib Glass},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c00934}
}
EUVIMED